Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by Laura R  – Israel, 2020-03-22 08:58  – Posting: # 21294
Views: 1,752

Hi, was wondering how P1 CROs are dealing with the COVID19 crisis, and if there is any chance to keep studies moving (in small cohorts, no overnight stays, etc).
Should HV studies considered an essential activity per the new FDA/EMA guidances, is voluteering in a Phase 1 study considered a valid reason to be outside? Laura

Complete thread:

 Admin contact
20,646 posts in 4,328 threads, 1,436 registered users;
online 21 (1 registered, 20 guests [including 16 identified bots]).
Forum time: 10:33 CEST (Europe/Vienna)

A little Learning is a dang’rous Thing;
Drink deep, or taste not the Pierian Spring:
There shallow Draughts intoxicate the Brain,
And drinking largely sobers us again.    Alexander Pope

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz